
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease
Author(s) -
Paola Conigliaro,
Maria Sole Chimenti,
Paola Triggianese,
Arianna D’Antonio,
Giorgia Sena,
Norma Alfieri,
Livia Biancone,
Roberto Perricone
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025122
Subject(s) - golimumab , medicine , adalimumab , infliximab , ulcerative colitis , gastroenterology , crohn's disease , refractory (planetary science) , inflammatory bowel disease , disease , physics , astrobiology